Transbiohope | Hospital 12 de Octubre actively recruiting in TRANSBIO clinical study
Transbio project, oriented to the development of an in vitro diagnostic kit for the treatment of chronic rejection with immunosuppressants. H2020 program of the European Union
"trasplante riñón” “diagnóstico in vitro” “in vitro diagnosis” “trasplante renal” “H2020” “European Commission project” “renal transplant” “kidney transplant” “start-up” “Tres Cantos” “biomedicina” “biomedicine” “biotechnology” “immunobiogram” “inmunobiograma” “tratamiento inmunosupresores” “Treatment with immunosuppressants”
16295
post-template-default,single,single-post,postid-16295,single-format-standard,ajax_fade,page_not_loaded,,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive
 

Hospital 12 de Octubre actively recruiting in TRANSBIO clinical study

Hospital 12 de Octubre actively recruiting in TRANSBIO clinical study

On October 2018, the Ethical Committee of the Hospital 12 de Octubre (Madrid) approved the inclusion of the hospital in the TRANSBIO clinical study and the Site Initiation Visit was performed on December 2018. Since then, 7 patients have been recruited.

The 9 centres involved in the TRANSBIO clinical study, based in 5 different countries (Spain, Germany, Polonia, Denmark and the USA), are actively recruiting in the planned rate, with a total of 179 patients enrolled to date.

With the 200 patients target sample size, we expect to confirm the  robustness, reliability and clinical consistency of IMMUNOBIOGRAM® as an in vitro test to adjust immunosuppressive therapy in a personalized way in patients with kidney transplantation.